NHE-64895-50829
2 vaccinations
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Moderna
-
2021-01-29
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-01
- 2021-02-03
-
2021-02-05
Health check-in — day 7, dose 1Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-02-05
- 2021-02-12
-
2021-02-26
Dose 2 — Moderna
-
2021-02-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: ItchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-05
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-12
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Persistent headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-02-26 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Itching
Release 5 — day 14, dose 2
Symptoms: Persistent headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release